These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 7526916

  • 1. Inhibition of phospholipase D of human platelets by protein tyrosine kinase inhibitors.
    Martinson EA, Scheible S, Presek P.
    Cell Mol Biol (Noisy-le-grand); 1994 Jul; 40(5):627-34. PubMed ID: 7526916
    [Abstract] [Full Text] [Related]

  • 2. The tyrosine kinase inhibitors, genistein and methyl 2,5-dihydroxycinnamate, inhibit the release of (3H)arachidonate from human platelets stimulated by thrombin or collagen.
    Hargreaves PG, Licking EF, Sargeant P, Sage SO, Barnes MJ, Farndale RW.
    Thromb Haemost; 1994 Oct; 72(4):634-42. PubMed ID: 7878644
    [Abstract] [Full Text] [Related]

  • 3. Secreted ADP plays a central role in thrombin-induced phospholipase D activation in human platelets.
    Martinson EA, Scheible S, Marx-Grunwitz A, Presek P.
    Thromb Haemost; 1998 Dec; 80(6):976-81. PubMed ID: 9869170
    [Abstract] [Full Text] [Related]

  • 4. Genistein, a protein tyrosine kinase inhibitor, inhibits thromboxane A2-mediated human platelet responses.
    Nakashima S, Koike T, Nozawa Y.
    Mol Pharmacol; 1991 Apr; 39(4):475-80. PubMed ID: 2017148
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of tyrosine kinase activity prevents the adhesive and cohesive properties of platelets and the expression of procoagulant activity in response to collagen.
    Diaz-Ricart M, Palomo M, Fuste B, Lopez-Vilchez I, Carbo C, Perez-Pujol S, White JG, Escolar G.
    Thromb Res; 2008 Apr; 121(6):873-83. PubMed ID: 17904203
    [Abstract] [Full Text] [Related]

  • 6. Rapid and transient translocation of PLC-gamma 1 to the cytoskeleton of thrombin-stimulated platelets. Evidence for a role of tyrosine kinases.
    Guinebault C, Payrastre B, Mauco G, Breton M, Plantavid M, Chap H.
    Cell Mol Biol (Noisy-le-grand); 1994 Jul; 40(5):687-93. PubMed ID: 7981623
    [Abstract] [Full Text] [Related]

  • 7. The roles of protein kinase C and tyrosine kinases in mediating endothelin-1-stimulated phospholipase D activity in rat myometrium: differential inhibition by ceramides and cyclic AMP.
    Le Stunff H, Dokhac L, Harbon S.
    J Pharmacol Exp Ther; 2000 Feb; 292(2):629-37. PubMed ID: 10640300
    [Abstract] [Full Text] [Related]

  • 8. Tyrosine kinase regulates phospholipase D activation at a point downstream from protein kinase C in osteoblast-like cells.
    Kozawa O, Suzuki A, Oiso Y.
    J Cell Biochem; 1995 Feb; 57(2):251-5. PubMed ID: 7759561
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Tyrosine kinases activate store-mediated Ca2+ entry in human platelets through the reorganization of the actin cytoskeleton.
    Rosado JA, Graves D, Sage SO.
    Biochem J; 2000 Oct 15; 351 Pt 2(Pt 2):429-37. PubMed ID: 11023829
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Phospholipase D in platelets and other cells.
    Vorland M, Thorsen VA, Holmsen H.
    Platelets; 2008 Dec 15; 19(8):582-94. PubMed ID: 19012176
    [Abstract] [Full Text] [Related]

  • 14. Cyclic AMP-insensitive activation of c-Src and Syk protein-tyrosine kinases through platelet membrane glycoprotein VI.
    Ichinohe T, Takayama H, Ezumi Y, Yanagi S, Yamamura H, Okuma M.
    J Biol Chem; 1995 Nov 24; 270(47):28029-36. PubMed ID: 7499287
    [Abstract] [Full Text] [Related]

  • 15. The effects of tyrphostins B42 and B46 on equine platelet function and protein tyrosine phosphorylation.
    Dillon AM, Heath MF.
    Biochem Biophys Res Commun; 1995 Jul 17; 212(2):595-601. PubMed ID: 7542881
    [Abstract] [Full Text] [Related]

  • 16. Role of guanine nucleotide-binding protein and tyrosine kinase in platelet-activating factor activation of phospholipase C in A431 cells: proposal for dual mechanisms.
    Thurston AW, Rhee SG, Shukla SD.
    J Pharmacol Exp Ther; 1993 Aug 17; 266(2):1106-12. PubMed ID: 7689100
    [Abstract] [Full Text] [Related]

  • 17. A tyrosine kinase signaling pathway, regulated by calcium entry and dissociated from tyrosine phosphorylation of phospholipase Cgamma-1, is involved in inositol phosphate production by activated G protein-coupled receptors in myometrium.
    Palmier B, Vacher M, Harbon S, Leiber D.
    J Pharmacol Exp Ther; 1999 May 17; 289(2):1022-30. PubMed ID: 10215683
    [Abstract] [Full Text] [Related]

  • 18. Platelet activation leads to increased c-src kinase activity and association of c-src with an 85-kDa tyrosine phosphoprotein.
    Wong S, Reynolds AB, Papkoff J.
    Oncogene; 1992 Dec 17; 7(12):2407-15. PubMed ID: 1281303
    [Abstract] [Full Text] [Related]

  • 19. Involvement of tyrosine phosphorylation in IgE receptor-mediated phospholipase D activation in rat basophilic leukemia (RBL-2H3) cells.
    Kumada T, Miyata H, Nozawa Y.
    Biochem Biophys Res Commun; 1993 Mar 31; 191(3):1363-8. PubMed ID: 7682071
    [Abstract] [Full Text] [Related]

  • 20. Tyrosine kinase blockers: new platelet activation inhibitors.
    Rendu F, Eldor A, Grelac F, Levy-Toledano S, Levitzki A.
    Blood Coagul Fibrinolysis; 1990 Dec 31; 1(6):713-6. PubMed ID: 2133252
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.